Cargando…
Altos Labs and the quest for immortality: but can we live longer right now?
Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040914/ https://www.ncbi.nlm.nih.gov/pubmed/35496979 http://dx.doi.org/10.18632/oncoscience.552 |
| _version_ | 1784694436795514880 |
|---|---|
| author | Blagosklonny, Mikhail V. |
| author_facet | Blagosklonny, Mikhail V. |
| author_sort | Blagosklonny, Mikhail V. |
| collection | PubMed |
| description | Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen. |
| format | Online Article Text |
| id | pubmed-9040914 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90409142022-04-29 Altos Labs and the quest for immortality: but can we live longer right now? Blagosklonny, Mikhail V. Oncoscience Research Perspective Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen. Impact Journals LLC 2022-04-22 /pmc/articles/PMC9040914/ /pubmed/35496979 http://dx.doi.org/10.18632/oncoscience.552 Text en https://creativecommons.org/licenses/by/3.0/Copyright: © 2022 Blagosklonny. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Research Perspective Blagosklonny, Mikhail V. Altos Labs and the quest for immortality: but can we live longer right now? |
| title | Altos Labs and the quest for immortality: but can we live longer right now? |
| title_full | Altos Labs and the quest for immortality: but can we live longer right now? |
| title_fullStr | Altos Labs and the quest for immortality: but can we live longer right now? |
| title_full_unstemmed | Altos Labs and the quest for immortality: but can we live longer right now? |
| title_short | Altos Labs and the quest for immortality: but can we live longer right now? |
| title_sort | altos labs and the quest for immortality: but can we live longer right now? |
| topic | Research Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040914/ https://www.ncbi.nlm.nih.gov/pubmed/35496979 http://dx.doi.org/10.18632/oncoscience.552 |
| work_keys_str_mv | AT blagosklonnymikhailv altoslabsandthequestforimmortalitybutcanwelivelongerrightnow |